Legion logo
Sign in

Science

SC
Biotech / BiopharmaAlamedaFounded 2021Website
#498 by valuation

Science is a clinical-stage medical technology company focused on developing neural interface systems to address conditions such as vision loss, cognitive impairment, and motor dysfunction. The company integrates neural recording electronics, optogenetic stimulation, and software platforms to create brain-computer interface (BCI) solutions. Its product suite includes Axon neural probes, the SciFi headstage, and the Synapse communication protocol, which together form a modular platform for neural engineering applications. Science also develops implantable devices like PRIMA, a wireless photovoltaic stimulation array aimed at restoring vision in patients with retinal degenerative diseases.​

$1.5B
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$1.5B
blended valuationfunding round
Mar 2, 2026$1.5BOct 19, 2026
All rounds
5 funding rounds, newest first.
RoundAnnouncedRaisedPost-money
Series CMar 5, 2026$230M$1.5B
Series CApr 14, 2025$121.6M$862.7M
Series AJan 1, 2025$35.7M$511.9M
Series AMay 23, 2024$26M$305.1M
Series AJul 6, 2021$47.3M$236.6M
Investors
31 investors across all rounds.
  • KV
    Khosla Ventures
  • LV
    Lightspeed Venture Partners
  • IQ
    IQT
  • QC
    Quiet Capital
  • CC
    Conversion Capital
  • FY
    Fifty Years
  • HC
    HOF Capital
  • YC
    Y Combinator
  • AV
    Artis Ventures
  • PL
    Protocol Labs
Only Legion members can view the full investor roster. Sign in to Legion

Invest in the private markets on Legion

Registered users see full trading activity, every investor, rankings, and live deals.

Get started

Data as of .